Annual Net Income
-$41.44 M
-$2.74 M-7.07%
31 December 2023
Summary:
Cardiff Oncology annual net profit is currently -$41.44 million, with the most recent change of -$2.74 million (-7.07%) on 31 December 2023. During the last 3 years, it has fallen by -$22.13 million (-114.64%). CRDF annual net income is now -1750.71% below its all-time high of -$2.24 million, reached on 31 December 2011.CRDF Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$11.86 M
-$77.00 K-0.65%
30 September 2024
Summary:
Cardiff Oncology quarterly net profit is currently -$11.86 million, with the most recent change of -$77.00 thousand (-0.65%) on 30 September 2024. Over the past year, it has dropped by -$2.12 million (-21.83%). CRDF quarterly net income is now -127573.12% below its all-time high of $9300.00, reached on 30 September 2011.CRDF Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$42.98 M
-$2.12 M-5.20%
30 September 2024
Summary:
Cardiff Oncology TTM net profit is currently -$42.98 million, with the most recent change of -$2.12 million (-5.20%) on 30 September 2024. Over the past year, it has dropped by -$2.18 million (-5.34%). CRDF TTM net income is now -7686.41% below its all-time high of -$552.00 thousand, reached on 31 March 2011.CRDF TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDF Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -7.1% | -21.8% | -5.3% |
3 y3 years | -114.6% | -71.5% | -68.9% |
5 y5 years | -151.8% | -186.3% | -163.2% |
CRDF Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -114.6% | at low | -71.5% | at low | -68.9% | at low |
5 y | 5 years | -152.5% | at low | -189.9% | at low | -163.2% | at low |
alltime | all time | -1750.7% | at low | <-9999.0% | at low | -7686.4% | at low |
Cardiff Oncology Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$11.86 M(+0.7%) | -$42.98 M(+5.2%) |
June 2024 | - | -$11.78 M(+17.7%) | -$40.86 M(+1.6%) |
Mar 2024 | - | -$10.01 M(+7.2%) | -$40.23 M(-2.9%) |
Dec 2023 | -$41.44 M(+7.1%) | -$9.34 M(-4.0%) | -$41.44 M(+1.6%) |
Sept 2023 | - | -$9.73 M(-12.7%) | -$40.80 M(+2.9%) |
June 2023 | - | -$11.15 M(-0.7%) | -$39.64 M(+1.8%) |
Mar 2023 | - | -$11.22 M(+29.0%) | -$38.93 M(+0.6%) |
Dec 2022 | -$38.70 M(+36.8%) | -$8.70 M(+1.5%) | -$38.70 M(-1.9%) |
Sept 2022 | - | -$8.57 M(-17.9%) | -$39.45 M(+4.4%) |
June 2022 | - | -$10.44 M(-5.0%) | -$37.79 M(+10.8%) |
Mar 2022 | - | -$10.99 M(+16.4%) | -$34.10 M(+20.6%) |
Dec 2021 | -$28.29 M(+46.5%) | -$9.44 M(+36.6%) | -$28.29 M(+11.2%) |
Sept 2021 | - | -$6.91 M(+2.3%) | -$25.45 M(+10.5%) |
June 2021 | - | -$6.76 M(+30.5%) | -$23.03 M(+12.9%) |
Mar 2021 | - | -$5.18 M(-21.5%) | -$20.40 M(+5.6%) |
Dec 2020 | -$19.31 M(+17.6%) | -$6.60 M(+46.7%) | -$19.31 M(+13.9%) |
Sept 2020 | - | -$4.50 M(+9.0%) | -$16.95 M(+2.1%) |
June 2020 | - | -$4.12 M(+0.9%) | -$16.60 M(-0.0%) |
Mar 2020 | - | -$4.09 M(-3.6%) | -$16.60 M(+1.1%) |
Dec 2019 | -$16.41 M(-0.3%) | -$4.24 M(+2.4%) | -$16.41 M(+0.5%) |
Sept 2019 | - | -$4.14 M(+0.4%) | -$16.33 M(+2.3%) |
June 2019 | - | -$4.13 M(+5.6%) | -$15.96 M(+2.4%) |
Mar 2019 | - | -$3.90 M(-6.1%) | -$15.58 M(-5.4%) |
Dec 2018 | -$16.46 M(-33.9%) | -$4.16 M(+10.3%) | -$16.46 M(+10.7%) |
Sept 2018 | - | -$3.77 M(+0.6%) | -$14.87 M(-3.4%) |
June 2018 | - | -$3.75 M(-21.7%) | -$15.39 M(-21.8%) |
Mar 2018 | - | -$4.79 M(+86.3%) | -$19.69 M(-20.9%) |
Dec 2017 | -$24.91 M | -$2.57 M(-40.1%) | -$24.91 M(-19.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2017 | - | -$4.29 M(-46.7%) | -$30.89 M(-16.0%) |
June 2017 | - | -$8.05 M(-19.5%) | -$36.78 M(-5.5%) |
Mar 2017 | - | -$10.00 M(+17.0%) | -$38.94 M(-0.7%) |
Dec 2016 | -$39.20 M(+42.7%) | -$8.55 M(-16.1%) | -$39.20 M(+3.1%) |
Sept 2016 | - | -$10.19 M(-0.1%) | -$38.04 M(+24.4%) |
June 2016 | - | -$10.20 M(-0.6%) | -$30.58 M(+0.1%) |
Mar 2016 | - | -$10.26 M(+39.0%) | -$30.56 M(+11.2%) |
Dec 2015 | -$27.47 M(+91.8%) | -$7.38 M(+169.8%) | -$27.47 M(+10.9%) |
Sept 2015 | - | -$2.74 M(-73.1%) | -$24.77 M(-9.6%) |
June 2015 | - | -$10.18 M(+41.9%) | -$27.41 M(+49.7%) |
Mar 2015 | - | -$7.17 M(+53.2%) | -$18.31 M(+27.8%) |
Dec 2014 | -$14.33 M(+21.3%) | -$4.68 M(-12.9%) | -$14.33 M(+34.2%) |
Sept 2014 | - | -$5.38 M(+399.0%) | -$10.67 M(+10.0%) |
June 2014 | - | -$1.08 M(-66.2%) | -$9.70 M(-30.2%) |
Mar 2014 | - | -$3.19 M(+210.0%) | -$13.89 M(+17.6%) |
Dec 2013 | -$11.81 M(+2.1%) | -$1.03 M(-76.6%) | -$11.81 M(-31.0%) |
Sept 2013 | - | -$4.40 M(-16.5%) | -$17.11 M(+28.1%) |
June 2013 | - | -$5.27 M(+374.5%) | -$13.36 M(+16.0%) |
Mar 2013 | - | -$1.11 M(-82.4%) | -$11.51 M(-0.4%) |
Dec 2012 | -$11.57 M(+416.5%) | -$6.33 M(+873.0%) | -$11.57 M(+78.3%) |
Sept 2012 | - | -$650.20 K(-81.0%) | -$6.49 M(+11.3%) |
June 2012 | - | -$3.43 M(+194.7%) | -$5.83 M(+104.5%) |
Mar 2012 | - | -$1.16 M(-6.8%) | -$2.85 M(+27.3%) |
Dec 2011 | -$2.24 M(-58.9%) | -$1.25 M(<-9900.0%) | -$2.24 M(+125.7%) |
Sept 2011 | - | $9300.00(-102.1%) | -$991.90 K(-0.9%) |
June 2011 | - | -$449.20 K(-18.6%) | -$1.00 M(+81.4%) |
Mar 2011 | - | -$552.00 K | -$552.00 K |
Dec 2010 | -$5.45 M | - | - |
FAQ
- What is Cardiff Oncology annual net profit?
- What is the all time high annual net income for Cardiff Oncology?
- What is Cardiff Oncology annual net income year-on-year change?
- What is Cardiff Oncology quarterly net profit?
- What is the all time high quarterly net income for Cardiff Oncology?
- What is Cardiff Oncology quarterly net income year-on-year change?
- What is Cardiff Oncology TTM net profit?
- What is the all time high TTM net income for Cardiff Oncology?
- What is Cardiff Oncology TTM net income year-on-year change?
What is Cardiff Oncology annual net profit?
The current annual net income of CRDF is -$41.44 M
What is the all time high annual net income for Cardiff Oncology?
Cardiff Oncology all-time high annual net profit is -$2.24 M
What is Cardiff Oncology annual net income year-on-year change?
Over the past year, CRDF annual net profit has changed by -$2.74 M (-7.07%)
What is Cardiff Oncology quarterly net profit?
The current quarterly net income of CRDF is -$11.86 M
What is the all time high quarterly net income for Cardiff Oncology?
Cardiff Oncology all-time high quarterly net profit is $9300.00
What is Cardiff Oncology quarterly net income year-on-year change?
Over the past year, CRDF quarterly net profit has changed by -$2.12 M (-21.83%)
What is Cardiff Oncology TTM net profit?
The current TTM net income of CRDF is -$42.98 M
What is the all time high TTM net income for Cardiff Oncology?
Cardiff Oncology all-time high TTM net profit is -$552.00 K
What is Cardiff Oncology TTM net income year-on-year change?
Over the past year, CRDF TTM net profit has changed by -$2.18 M (-5.34%)